Terns Pharmaceuticals (TERN) EPS (Weighted Average and Diluted) (2021 - 2023)
Historic EPS (Weighted Average and Diluted) for Terns Pharmaceuticals (TERN) over the last 3 years, with Q4 2023 value amounting to -$0.29.
- Terns Pharmaceuticals' EPS (Weighted Average and Diluted) fell 7058.82% to -$0.29 in Q4 2023 from the same period last year, while for Dec 2023 it was -$1.27, marking a year-over-year increase of 2573.1%. This contributed to the annual value of -$1.12 for FY2024, which is 1181.1% up from last year.
- Latest data reveals that Terns Pharmaceuticals reported EPS (Weighted Average and Diluted) of -$0.29 as of Q4 2023, which was down 7058.82% from -$0.42 recorded in Q3 2023.
- Over the past 5 years, Terns Pharmaceuticals' EPS (Weighted Average and Diluted) peaked at -$0.17 during Q4 2022, and registered a low of -$0.63 during Q4 2021.
- In the last 3 years, Terns Pharmaceuticals' EPS (Weighted Average and Diluted) had a median value of -$0.43 in 2022 and averaged -$0.41.
- Per our database at Business Quant, Terns Pharmaceuticals' EPS (Weighted Average and Diluted) surged by 7306.53% in 2022 and then tumbled by 7058.82% in 2023.
- Over the past 3 years, Terns Pharmaceuticals' EPS (Weighted Average and Diluted) (Quarter) stood at -$0.63 in 2021, then surged by 73.07% to -$0.17 in 2022, then tumbled by 70.59% to -$0.29 in 2023.
- Its EPS (Weighted Average and Diluted) was -$0.29 in Q4 2023, compared to -$0.42 in Q3 2023 and -$0.25 in Q2 2023.